Pharmafile Logo
Pharmafocus logo
Advanced Search
handshake

Chiesi partners with Key2Brain to develop therapies for rare neurodegenerative diseases

June 12, 2025
Manufacturing and Production, Mergers and Acquisitions, Research and Development Chiesi Group, Key2Brain, Neurology, Rare Diseases, lysosomal storage disorders, neurodegenerative disease, partnership, ultra-rare disease

Italian biopharma, Chiesi Group, and Key2Brain, a Swedish biotech, have agreed to advance the development of two blood-brain barrier (BBB)-crossing …

News

Treatment for serious eye disease approved in Scotland

June 12, 2025
Market Access, Marketing Services, Research and Development, Sales and Marketing LYTENAVA, Opthalmology, Scottish Medicines Consortium, clinical programme, european union, eye disease, market approval, strategic partnership, united kingdom, wet age-related macular degeneration

Outlook Therapeutics has announced the Scottish Medicines Consortium (SMC) approval of Lytenava (bevacizumab gamma) for the treatment of wet age-related …

News
cellectis

PEPperPRINT launches new peptide microarray platform on 15th anniversary

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, PEPperPRINT, biotech research, peptide microarray platform

German biotech PEPperPRINT has marked its 15th anniversary with the launch of a new peptide microarray platform, combinatorial laser-induced forward …

News

Meteor Biotech opens site at UCLA to support biotech research

June 11, 2025
Biotech/start-up, Research and Development, Sales and Marketing Devices, Immunology, Meteor Biotech, Oncology, Pharmacy, University of California Los Angeles, cell sorting technology, clinical trials, research facility

South Korean spatial omics specialist, Meteor Biotech, has announced the opening of its first international office at the California NanoSystems …

News
handshake_2

BioDuro and Silicogenix collaborate to advance non-traditional drug development

June 11, 2025
Manufacturing Services, Manufacturing and Production, Research and Development BioDuro, Oncology, Pharmacy, Silicogenix, contract research, contract research development and manufacturing organisation (CRDMO), drug development

BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …

News
clinical_trials

Dupixent improves symptoms in patients with skin of colour, study shows

June 11, 2025
Advocacy Development, Medical Education, Research and Development Dermatology, Dupixent, Regeneron, Sanofi, atopic dermatitis, dermatology, underserved populations

Sanofi and Regeneron have announced results from the collaborative phase 4 DISCOVER study, presented at the Revolutionizing Atopic Dermatitis Conference, …

News

Lubrizol announces an important milestone for its novelpatented excipient, Apisolex™ polymer

June 10, 2025
Research and Development Apisolex polymer, Good Manufacturing Practices (GMP) guidelines, Lubrizol, Pharmacy, clinical trial

June 10, 2025 – Lubrizol announces that an Apisolex™ polymer excipient-enabled drugformulation is in Phase 1 clinical trials. Introduced to …

News
Press release

Takeda presents positive results from trial of chronic kidney disease treatment

June 10, 2025
Research and Development European Renal Association, Immunology, Nephrology, Takeda, autoimmune disease, immunoglobulin A nephropathy (IgAN), kidney disease

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A …

News
Publishing image

ANGLE’s Parsortix system used in new cancer biology research

June 10, 2025
Medical Communications, Research and Development Angle, Oncology, Parsortix system, R&D, biotech, oncology, scientific journals

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in …

News

Hansa Biopharma to host investor event on Guillain-Barré Syndrome to accelerate research

June 10, 2025
Conferencing, Events & Incentives, Interactive Conferences, Medical Communications, Research and Development, Sales and Marketing Guillain-Barré syndrome, Hansa Biopharma, Immunology, Neurology, investor event

Hansa Biopharma (Hansa) will host a virtual investor event on Guillain-Barré syndrome (GBS) on 16 June 2025. The webcast aims …

News

Vertex presents promising new data from cystic fibrosis trials

June 9, 2025
Medical Communications, Research and Development European Cystic Fibrosis Conference, Rare Diseases, Vertex, clinical trial, cystic fibrosis

Vertex Pharmaceuticals has presented new data showing the clinical and quality-of-life benefits of its cystic fibrosis (CF) therapies, particularly Alyftrek …

News
hsm_mobile_clinical_trial_istock-872676342

Corcept reports survival benefit in ALS trial of dazucorilant despite missing primary endpoint

June 9, 2025
Research and Development Corcept Therapeutics, European Network to Cure ALS (ENCALS), Neurology, amyotrophic lateral sclerosis, clinical trial

Corcept Therapeutics has announced results from its phase 2 DAZALS study investigating dazucorilant in patients with amyotrophic lateral sclerosis (ALS), …

News
baby-2416718_1280

Study into treatment for rare condition in premature infants launches globally

June 9, 2025
Research and Development Chiesi Farmaceutici, Elgan Pharma, Gastrointestinal tract, Paediatrics, clinical trial, intestinal malabsorption, premature infant health

Elgan Pharma, specialising in neonatology, and Italy-based biopharma, Chiesi Farmaceutici, have announced the dosing of the first participating infants in …

News

The unbearable lightness of creativity

June 9, 2025
Medical Communications, Sales and Marketing 21GRAMS, Atomic Matter, Corporate, HAVAS LYNX, London UK, PM Society Awards, Pharmacy, pharma healthcare communications, pharma marketing

21GRAMS and Havas Lynx lead the charge at the PM Society Awards for pharma marketing and healthcare communications Commenting on …

Feature
laboratory-testing-az

Trial into rare genetic disease Werner syndrome reports promising results

June 6, 2025
Research and Development Chiba University, Niagen Bioscience, Rare Diseases, Werner Syndrome, clinical trial, rare genetic disease

Researchers at Chiba University, Japan, alongside Niagen Bioscience, have reported successful results from the world’s first trial of nicotinamide riboside …

News

Osivax reaches key milestone in phase 2a trial for broad-spectrum flu vaccine

June 6, 2025
Research and Development Ghent University Hospital, Osivax, Vaccine, Virology, clinical trial, influenza a

Osivax has announced the completion of patient visits in its phase 2a trial evaluating a booster dose of OVX836, a …

News

BioNTech and Bristol Myers Squibb collaborate on bispecific antibody for solid tumours

June 6, 2025
Research and Development BioNTech, Oncology, bispecific antibody treatment, bristol myers squibb, oncology, partnership

BioNTech and Bristol Myers Squibb (BMS) have entered a partnership to collaboratively develop and commercialise BNT327, BioNTech’s bispecific antibody, to …

News

Roche’s Evrysdi tablet approved in EU for spinal muscular atrophy

June 5, 2025
Research and Development European Commission, Evrysdi, Neurology, Roche, european union, neuromuscular condition, spinal muscular atrophy (SMA)

Roche has received approval from the European Commission for a new tablet formulation of Evrysdi (risdiplam), marking the first and …

News
lab

Study links COVID-19 and some vaccines to increased risk of rare neurological condition

June 5, 2025
Medical Communications, Medical Education, Medical/ Scientific Writing, Research and Development COVID-19, COVID-19 vaccine, Guillain-Barré Syndrome (GBS), Neurology, Virology, adenoviral vector vaccines, mRNA-based vaccines, medical study, neurological condition

An international study has found an increased risk of Guillain-Barré syndrome (GBS) following SARS-CoV-2 infection and after vaccination with adenoviral …

News

Brenntag acquires mcePharma to expand GMP capabilities in biopharma services

June 5, 2025
Manufacturing and Production, Mergers and Acquisitions Brenntag Specialities, Corporate, acquisition, continuous monitoring platform (CMP), mcePharma

Brenntag Specialties has acquired Czech-based mcePharma, strengthening its position in the pharma and biopharma industries through expanded continuous monitoring platform …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026